News

The probe was taken over by the CBI following directions from the Kerala High Court, based on a petition filed by activist ...
Good morning, and welcome to the Principal Financial Group First Quarter 2025 Financial Results Conference Call. There will be a question-and-answer period after the speakers have completed their ...
Days after the Women’s Health Initiative, one of the largest and longest women’s health studies in the world, announced that ...
B. Riley lowered the firm’s price target on PDS Biotechnology (PDSB) to $5 from $7 and keeps a Buy rating on the shares. The firm cites PDS01 ...
BriaCell Therapeutics (TSX:BCT), a Canadian biotechnology stock developing cancer immunotherapies, announced the resolution ...
PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today ...
For biologists, seeing is believing. But sometimes biologists have a hard time seeing. One particularly vexing challenge is ...